Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Exalenz has previously gathered information in a previous study on patients with chronic liver disease including the methacetin breath test. Several years later, the company wishes to investigate this group of subjects and see retrospectively if the breath test was a predictor of complications related to their liver disease.